About Research at UPMC Hillman Cancer Center
UPMC Hillman Cancer Center (Hillman) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center - one of only 56 in the U.S.
At UPMC Hillman Cancer Center, our researchers collaborate with our clinician-scientists to advance the most promising laboratory studies into novel clinical trials in order to provide patients with early access to new and innovative treatments.
The nationally and internationally renowned research at UPMC Hillman Cancer Center includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care.
We are also dedicated to the education and training of the next generation of cancer researchers and physicians, as well as the ongoing recruitment of world-renowned scientists.
UPMC Hillman Cancer Center is the only NCI-designated Comprehensive Cancer Center in western Pennsylvania. We are dedicated to excellence for our patients, and we are working to make vast strides in the global effort to reduce the burden of cancer.
Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center and the preeminent institution in western Pennsylvania for providing cancer care; conducting basic, translational, clinical, and population science research; and educating the next generation of cancer researchers and physicians.
We have more than 300 researchers across our programs, who are quickly advancing the latest research discoveries into pioneering therapies that can benefit the more than 130,000 patients seen each year throughout our integrated cancer care delivery network. Read more.